Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AU4G
|
|||
| Drug Name |
3-amino-5-benzyl-substituted indazole derivative 1
|
|||
| Synonyms |
PMID28270021-Compound-WO2010106028Entrectinib (RXDX-101)
Click to Show/Hide
|
|||
| Indication | Chronic pain [ICD-11: MG30; ICD-10: R52.1, R52.2; ICD-9: 338.2, 780] | Patented | [1] | |
| Neuropathic pain [ICD-11: 8E43.0] | Patented | [1] | ||
| Pruritus [ICD-11: EC90; ICD-10: L29, L29.9] | Patented | [1] | ||
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Patented | [1] | ||
| Thymic cancer [ICD-11: 2C27; ICD-10: C37] | Patented | [1] | ||
| Company |
NERVIANO MEDICAL
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.Expert Opin Ther Pat. 2017 Jul;27(7):831-849. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.